261000: Codeine phosphate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Opioid receptor agonist\Phenanthrene derivative (substance)\Codeine phosphate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Opioid receptor agonist\Phenanthrene derivative (substance)\Codeine phosphate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Phenanthrene derivative (substance)\Codeine phosphate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Psychoactive substance (substance)\Central depressant\Phenanthrene derivative (substance)\Codeine phosphate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic cyclic compound\Heterocyclic compound\Alkaloid (substance)\Naturally occurring alkaloid (substance)\Plant alkaloid\Plant isoquinoline alkaloid\Morphinane alkaloid (substance)\Codeine phosphate

\Hydrocarbon\Aromatic hydrocarbon (substance)\Phenanthrene\Phenanthrene derivative (substance)\Codeine phosphate

\Substance categorized functionally\Phytochemical\Plant alkaloid\Plant isoquinoline alkaloid\Morphinane alkaloid (substance)\Codeine phosphate

\Material (substance)\Natural material\Organic natural material\Plant material\...

\Phytochemical\Plant alkaloid\Plant isoquinoline alkaloid\Morphinane alkaloid (substance)\Codeine phosphate

\Plant product\Plant alkaloid\Plant isoquinoline alkaloid\Morphinane alkaloid (substance)\Codeine phosphate

\Biological substance (substance)\Organic natural material\Plant material\...

\Phytochemical\Plant alkaloid\Plant isoquinoline alkaloid\Morphinane alkaloid (substance)\Codeine phosphate

\Plant product\Plant alkaloid\Plant isoquinoline alkaloid\Morphinane alkaloid (substance)\Codeine phosphate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1525019 Codeine phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

756492018 Codeine phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4842731000005119 codeinphosphathemihydrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Codeine phosphate	Is a	Product containing codeine (medicinal product)	false	Inferred relationship	Some
Codeine phosphate	Is a	phosphatsalt	false	Inferred relationship	Some
Codeine phosphate	Is a	Opiate agonist (substance)	false	Inferred relationship	Some
Codeine phosphate	Is a	Opioid receptor agonist	false	Inferred relationship	Some
Codeine phosphate	Is a	Codeine (substance)	false	Inferred relationship	Some
Codeine phosphate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Opioid receptor agonist (disposition)	true	Inferred relationship	Some
Codeine phosphate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Codeine (substance)	true	Inferred relationship	Some
Codeine phosphate	Is a	Phenanthrene derivative (substance)	true	Inferred relationship	Some
Codeine phosphate	Is a	Morphinane alkaloid (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Codeine phosphate [gastro-intestinal use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphatprodukt	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 15mg/5mL linctus	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 15mg/5mL diabetic linctus	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat mikstur til børn a 3 mg/5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat sukkerfri mikstur a 15 mg/5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate [analgesic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 60 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 25 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 60 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphatpulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 4,56 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 5 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
paracetamol 120 mg + alkohol 7%v v + codeinphosphat 12 mg eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
paracetamol 120 mg + codeinphosphat 12 mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 10 mg + promethazinhydrochlorid 6,25 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 10 mg + pseudoephedrinhydrochlorid 30 mg + triprolidinhydrochlorid 1,25 mg væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 30 mg/1 ml injektion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Aspirin 325 mg and carisoprodol 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing aspirin and carisoprodol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
acetylsalicylsyre + butalbital + caffein + codeinphosphat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
paracetamol + alkohol + codeinphosphat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
paracetamol + butalbital + caffein + codeinphosphat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
acetylsalicylsyre + carisoprodol + codeinphosphat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat + promethazinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat + pseudoephedrinhydrochlorid + triprolidinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
codeinphosphat 10 mg/10 ml + kaolin 3 g/10 ml mikstur	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Acetaminophen + codeine phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
co-codamol 8 mg + 500 mg dispergibel tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 15 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 12.5 mg and ibuprofen 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate 12.8 mg and ibuprofen 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
ibuprofen 300 mg + codeinphosphat 20 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
fioricet med codein 325 mg/50 mg/40 mg/30 mg, kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Product containing codeine and guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some
Codeine phosphate hemihydrate (substance)	Is a	False	Codeine phosphate	Inferred relationship	Some
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	2
Codeine phosphate 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 60 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 60 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 12.8 mg and ibuprofen 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 12.8 mg and ibuprofen 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	2
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	2
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	2
Codeine phosphate 30 mg and paracetamol 500 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	4
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 12.5 mg and ibuprofen 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 12.5 mg and ibuprofen 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 15 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 15 mg and paracetamol 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	2
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Codeine phosphate	Inferred relationship	Some	1
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate hemihydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Codeine phosphate	Inferred relationship	Some
Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	3
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Codeine phosphate	Inferred relationship	Some	1
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Codeine phosphate	Inferred relationship	Some	2
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Codeine phosphate	Inferred relationship	Some	2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Codeine phosphate	Inferred relationship	Some	2

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1525019	Codeine phosphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
756492018	Codeine phosphate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4842731000005119	codeinphosphathemihydrat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)